[{"NetIncomeLoss_1_Q1_USD":117000000.0,"DerivativeFairValueOfDerivativeAssetAmountOffsetAgainstCollateral_0_Q1_USD":6000000.0,"IncomeTaxReconciliationOtherReconcilingItems_1_Q1_USD":-1000000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-61000000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures_1_Q1_USD":-4000000.0,"ProceedsFromDivestitureOfBusinesses_1_Q1_USD":19000000.0,"AssetsCurrent_0_Q1_USD":1696000000.0,"Depreciation_1_Q1_USD":32000000.0,"DerivativeAssets_0_Q1_USD":16000000.0,"EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense_1_Q1_USD":2000000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-554000000.0,"InventoryFinishedGoodsNetOfReserves_0_Q1_USD":303000000.0,"AccruedLiabilitiesCurrent_0_Q1_USD":557000000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q1_USD":0.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-103000000.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q1_shares":1100000.0,"OtherNoncashIncomeExpense_1_Q1_USD":-17000000.0,"RestructuringCharges_1_Q1_USD":3000000.0,"ShareBasedCompensation_1_Q1_USD":13000000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-90000000.0,"Assets_0_Q1_USD":9137000000.0,"InventoryWorkInProcessNetOfReserves_0_Q1_USD":75000000.0,"CommonStockSharesIssued_0_Q1_shares":264500000.0,"TreasuryStockValue_0_Q1_USD":2468000000.0,"GoodwillImpairedAccumulatedImpairmentLoss_0_Q1_USD":2893000000.0,"InventoryValuationReserves_0_Q1_USD":95000000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":33000000.0,"TreasuryStockShares_0_Q1_shares":46300000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":448000000.0,"ProceedsFromIssuanceOfLongTermDebt_1_Q1_USD":4000000.0,"IncreaseDecreaseInAccountsAndNotesReceivable_1_Q1_USD":-11000000.0,"IncomeTaxReconciliationDispositionOfBusiness_1_Q1_USD":4000000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":385000000.0,"RepaymentsOfLongTermDebt_1_Q1_USD":0.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":168000000.0,"IndefiniteLivedIntangibleAssetsExcludingGoodwill_0_Q1_USD":627000000.0,"AccountsNotesAndLoansReceivableNetCurrent_0_Q1_USD":643000000.0,"DerivativeCollateralObligationToReturnCash_0_Q1_USD":0.0,"CommonStockValue_0_Q1_USD":3000000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":32000000.0,"OtherNonoperatingIncomeExpense_1_Q1_USD":9000000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-81000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":219900000.0,"TreasuryStockValueAcquiredCostMethod_1_Q1_USD":90000000.0,"DerivativeCollateralObligationToReturnSecurities_0_Q1_USD":10000000.0,"MinorityInterest_0_Q1_USD":3000000.0,"EarningsPerShareBasic_1_Q1_USD":0.53,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":1285000000.0,"ProceedsFromDerivativeInstrumentInvestingActivities_1_Q1_USD":0.0,"ResearchAndDevelopmentExpense_1_Q1_USD":37000000.0,"IncreaseDecreaseInOtherNoncurrentAssets_1_Q1_USD":13000000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":-13000000.0,"DerivativeCollateralRightToReclaimCash_0_Q1_USD":0.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":3746000000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-53000000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_1_Q1_USD":13000000.0,"Liabilities_0_Q1_USD":4207000000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":125000000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":318000000.0,"OtherAssetsNoncurrent_0_Q1_USD":102000000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":56000000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":-17000000.0,"GoodwillWrittenOffRelatedToSaleOfBusinessUnit_1_Q1_USD":3000000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":27000000.0,"IncreaseDecreaseInInventories_1_Q1_USD":50000000.0,"GainLossOnSaleOfBusiness_1_Q1_USD":13000000.0,"DerivativeLiabilityFairValueGrossAsset_0_Q1_USD":0.0,"DerivativeAssetFairValueGrossLiability_0_Q1_USD":0.0,"DerivativeFairValueOfDerivativeLiability_0_Q1_USD":20000000.0,"ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill_1_Q1_USD":0.0,"NetIncomeLossAttributableToNoncontrollingInterest_1_Q1_USD":0.0,"DerivativeCollateralRightToReclaimSecurities_0_Q1_USD":10000000.0,"DerivativeFairValueOfDerivativeLiabilityAmountOffsetAgainstCollateral_0_Q1_USD":10000000.0,"LIFOInventoryAmount_0_Q1_USD":1000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q1_USD":318000000.0,"InterestExpense_1_Q1_USD":14000000.0,"TreasuryStockAcquiredAverageCostPerShare_1_Q1_USD":60.62,"AccountsPayableCurrent_0_Q1_USD":283000000.0,"LiabilitiesCurrent_0_Q1_USD":1212000000.0,"PaymentsToAcquireProductiveAssets_1_Q1_USD":30000000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":235000000.0,"DividendsCash_1_Q1_USD":22000000.0,"CommonStockDividendsPerShareCashPaid_1_Q1_USD":0.1,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":49000000.0,"OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax_1_Q1_USD":-99000000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q1_USD":13000000.0,"ProceedsFromSaleOfPropertyPlantAndEquipment_1_Q1_USD":0.0,"InventoryRawMaterialsAndSuppliesNetOfReserves_0_Q1_USD":122000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":218800000.0,"ProceedsFromStockOptionsExercised_1_Q1_USD":33000000.0,"SeveranceCosts1_1_Q1_USD":3000000.0,"LongTermDebtNoncurrent_0_Q1_USD":1923000000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":758000000.0,"PaymentsOfDividends_1_Q1_USD":22000000.0,"ProceedsFromPaymentsForOtherFinancingActivities_1_Q1_USD":-8000000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":411000000.0,"NumberOfOperatingSegments_1_Q1_segment":2.0,"FiniteLivedIntangibleAssetsNet_0_Q1_USD":1834000000.0,"IncomeTaxEffectsAllocatedDirectlyToEquityEmployeeStockOptions_1_Q1_USD":546000000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q1_USD":4930000000.0,"AdditionalPaidInCapital_0_Q1_USD":6618000000.0,"DerivativeFairValueOfDerivativeAsset_0_Q1_USD":16000000.0,"GrossProfit_1_Q1_USD":579000000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":2461000000.0,"AccruedIncomeTaxesCurrent_0_Q1_USD":44000000.0,"InventoryAdjustments_0_Q1_USD":2000000.0,"Goodwill_0_Q1_USD":3952000000.0,"AmortizationOfFinancingCosts_1_Q1_USD":2000000.0,"EarningsPerShareDiluted_1_Q1_USD":0.53,"CommonStockSharesOutstanding_0_Q1_shares":218200000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-8000000.0,"OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax_1_Q1_USD":5000000.0,"PaymentsForRepurchaseOfCommonStock_1_Q1_USD":90000000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments_1_Q1_USD":149000000.0,"OperatingIncomeLoss_1_Q1_USD":154000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":1027000000.0,"CommonStockSharesAuthorized_0_Q1_shares":400000000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":27000000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":92000000.0,"LineOfCreditFacilityRemainingBorrowingCapacity_0_Q1_USD":1139000000.0,"TreasuryStockSharesAcquired_1_Q1_shares":1500000.0,"GoodwillGross_0_Q1_USD":6845000000.0,"RestructuringCostsAndAssetImpairmentCharges_1_Q1_USD":1000000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":1.0,"InventoryNet_0_Q1_USD":500000000.0,"GoodwillPurchaseAccountingAdjustments_1_Q1_USD":-3000000.0,"OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax_1_Q1_USD":-4000000.0,"FiniteLivedIntangibleAssetsGross_0_Q1_USD":3119000000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-120000000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":1328000000.0,"DebtCurrent_0_Q1_USD":328000000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition_1_Q1_USD":3000000.0,"ProceedsFromRepaymentsOfShortTermDebt_1_Q1_USD":30000000.0,"StockholdersEquity_0_Q1_USD":4927000000.0,"GoodwillAcquiredDuringPeriod_1_Q1_USD":33000000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":536000000.0,"ProfitLoss_1_Q1_USD":117000000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":13000000.0,"DerivativeLiabilities_0_Q1_USD":20000000.0,"PreferredStockSharesAuthorized_0_Q1_shares":250000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":9137000000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-3000000.0,"PreferredStockValue_0_Q1_USD":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":44000000.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q1_USD":27000000.0,"Ticker":"XRAY","CIK":"818479","name":"DENTSPLY SIRONA INC.","OfficialName":"DENTSPLY SIRONA Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"9092055663.0","Country":"United States","Sector":"Health Care","Industry":"Medical\/Dental Instruments","Market":"NASDAQ","SP500":"SP500","filed":"20210506"}]